Amgen Inc (NASDAQ:AMGN)

163.46
Data as of Dec 26
 +2.79 / +1.74%
Today’s Change
108.20
Today|||52-Week Range
173.14
+43.29%
Year-to-Date
BioLineRx Out-Licences Skin Lesion Treatment Candidate - Analyst Blog
Dec 26 / Zacks.com
Why Is George Soros Buying This Beaten Down Biotech Stock?
Dec 21 / MotleyFool.com
BioCryst Rises on Positive Ebola Candidate Results - Analyst Blog
Dec 26 / Zacks.com
Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog
Dec 19 / Zacks.com
Stock Market News for December 26, 2014 - Market News
Dec 26 / Zacks.com
Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
Dec 19 / Zacks.com
After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog
Dec 26 / Zacks.com
Second time lucky in biotech shares
Dec 19 / FT.com
4 Biotech Stocks that Doubled in 2014 - Analyst Blog
Dec 26 / Zacks.com
Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog
Dec 18 / Zacks.com
3 Pharma Giants Growing Significantly Faster Than GlaxoSmithKline PLC
Dec 26 / MotleyFool.com
Novartis Successfully Expands Signifor Label in the U.S. - Analyst Blog
Dec 17 / Zacks.com
Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog
Dec 24 / Zacks.com
Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog
Dec 16 / Zacks.com
Endo/BioDelivery File Regulatory Application for Pain Drug - Analyst Blog
Dec 24 / Zacks.com
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Dec 16 / Zacks.com
Are There Any Winners Left In The Biotech Space?
Dec 24 / Benzinga
Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog
Dec 16 / Zacks.com
Stock Market News for December 24, 2014 - Market News
Dec 24 / Zacks.com
OPKO Up on Announcing Global Partnership with Pfizer - Analyst Blog
Dec 16 / Zacks.com
Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
Dec 23 / Zacks.com
4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog
Dec 16 / Zacks.com
Medivation Licenses CureTech's Cancer Drug Pidilizumab - Analyst Blog
Dec 23 / Zacks.com
Stock Market News for December 16, 2014 - Market News
Dec 16 / Zacks.com
Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog
Dec 22 / Zacks.com
A Shift From Healthcare To Discretionary
Dec 16 / StockTwits
AstraZeneca's Lynparza Cleared in U.S. for Ovarian Cancer - Analyst Blog
Dec 22 / Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog
Dec 15 / Zacks.com
AbbVie's All-Oral, Interferon-Free HCV Treatment Approved - Analyst Blog
Dec 22 / Zacks.com
Jazz Pharmaceuticals Starts Defibrotide Rolling NDA Filing - Analyst Blog
Dec 15 / Zacks.com
Celgene Gets Positive CHMP Recommendation for Revlimid - Analyst Blog
Dec 22 / Zacks.com
Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog
Dec 15 / Zacks.com
Right and Wrong
Dec 22 / TheStreet.com
Puma Biotechnology Reveals Positive Interim PB272 Data - Analyst Blog
Dec 15 / Zacks.com
Buying These 3 Stocks Is Like Making a Bet in a Burning House
Dec 22 / MotleyFool.com
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Dec 15 / MotleyFool.com
The Most Disappointing Clinical Failures in 2014
Dec 21 / MotleyFool.com
US oil stocks drop as crude prices slide
Dec 08 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.